Özge Özkaya

| A team of researchers presented the case of a patient with warm autoimmune hemolytic anemia (wAIHA) and primary myelofibrosis (MF).

| Transthyretin amyloid polyneuropathy (ATTR-PN) should be considered as a differential diagnosis in cases of idiopathic polyneuropathy, according

Some patients with myasthenia gravis (MG) have persistent symptoms and exacerbations as well as drug-related adverse events, according to a new study published in the European Journal of Neurology

| Myasthenia gravis (MG) is becoming more common in the Czech Republic, according to a new study published in the journal Neurology and

| Initial therapy with ursodeoxycholic acid (UDCA) leads to a normalization of alkaline phosphatase (ALP) levels compared to conventional

| Serum levels of connective tissue growth factor (CTGF) directly correlate with the degree of hepatic fibrosis in patients with primary

| A unique subtype of senescent biliary epithelial cells expressing programmed death-ligand 1 (PD-L1) associated with cyclic GMP-AMP

| Neuropsychiatric symptoms, especially emotional dysregulation, and decreased motivation, are common and clinically relevant in patients with Friedreich ataxia (FA), found a new study published in Scientific Reports

Tafamidis treatment improves clinical outcomes and limits the progression of cardiac remodeling in patients with transthyretin-mediated amyloid cardiomyopathy (ATTR-CM), according to a new study published in JACC: Advances

| ATLAS 2030, the medical lower-body exoskeleton for children is safe for patients with spinal muscular atrophy (SMA) and cerebral palsy (CP), according to a new study published in the scientific journal Children